{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:56:29Z","timestamp":1790092589543,"version":"4.0.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"DOI":"10.1038\/s41589-026-02228-8","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:40Z","timestamp":1779958960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma"],"prefix":"10.1038","author":[{"given":"Michael P.","family":"Agius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hevenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Connor","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romanos Sklavenitis","family":"Pistofidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-2102","authenticated-orcid":false,"given":"Hyuk-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-015X","authenticated-orcid":false,"given":"Daniel","family":"Heilpern-Mallory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Heaslip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu J.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puspalata","family":"Bashyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-5726","authenticated-orcid":false,"given":"Michelle P.","family":"Aranha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lightbody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-689X","authenticated-orcid":false,"given":"Ralph","family":"Mazitschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-5929","authenticated-orcid":false,"given":"Sirano","family":"Dhe-Paganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2321-8005","authenticated-orcid":false,"given":"Constantine S.","family":"Mitsiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-3092","authenticated-orcid":false,"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-3356","authenticated-orcid":false,"given":"Jun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2228_CR1","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3389\/fimmu.2018.02622","volume":"9","author":"CD Thompson","year":"2018","unstructured":"Thompson, C. D., Matta, B. & Barnes, B. J. Therapeutic targeting of IRFs: pathway-dependence or structure-based? Front. Immunol. 9, 2622 (2018).","journal-title":"Front. Immunol."},{"key":"2228_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cyto.2017.02.006","volume":"98","author":"B Matta","year":"2017","unstructured":"Matta, B., Song, S., Li, D. & Barnes, B. J. Interferon regulatory factor signaling in autoimmune disease. Cytokine 98, 15\u201326 (2017).","journal-title":"Cytokine"},{"key":"2228_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-0716-2815-7_9","volume":"2594","author":"Z Tao","year":"2023","unstructured":"Tao, Z. & Wu, X. Targeting transcription factors in cancer: from \u2018undruggable\u2019 to \u2018druggable\u2019. Methods Mol. Biol. 2594, 107\u2013131 (2023).","journal-title":"Methods Mol. Biol."},{"key":"2228_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller, J. H. Targeting transcription factors in cancer\u2014from undruggable to reality. Nat. Rev. Cancer 19, 611\u2013624 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2228_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct. Target. Ther. 6, 402 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2228_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18084","volume":"28","author":"HG Xu","year":"2024","unstructured":"Xu, H. G., Chen, C., Chen, L. Y. & Pan, S. Pan-cancer analysis identifies the IRF family as a biomarker for survival prognosis and immunotherapy. J. Cell. Mol. Med. 28, e18084 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"2228_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.leukres.2018.07.025","volume":"72","author":"A Agnarelli","year":"2018","unstructured":"Agnarelli, A., Chevassut, T. & Mancini, E. J. IRF4 in multiple myeloma\u2014biology, disease and therapeutic target. Leuk. Res. 72, 52\u201358 (2018).","journal-title":"Leuk. Res."},{"key":"2228_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer, A. L. et al. IRF4 addiction in multiple myeloma. Nature 454, 226\u2013231 (2008).","journal-title":"Nature"},{"key":"2228_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria, I. et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118, 139\u2013147 (2011).","journal-title":"Blood"},{"key":"2228_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2006.07.009","volume":"25","author":"R Sciammas","year":"2006","unstructured":"Sciammas, R. et al. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25, 225\u2013236 (2006).","journal-title":"Immunity"},{"key":"2228_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng1097-226","volume":"17","author":"S Iida","year":"1997","unstructured":"Iida, S. et al. Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17, 226\u2013230 (1997).","journal-title":"Nat. Genet."},{"key":"2228_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr, J. G. et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell 25, 91\u2013101 (2014).","journal-title":"Cancer Cell"},{"key":"2228_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s43018-023-00550-x","volume":"4","author":"R de Matos Simoes","year":"2023","unstructured":"de Matos Simoes, R. et al. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nat. Cancer 4, 754\u2013773 (2023).","journal-title":"Nat. Cancer"},{"key":"2228_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2009.12.005","volume":"22","author":"W Chen","year":"2010","unstructured":"Chen, W. & Royer Jr, W. E. Structural insights into interferon regulatory factor activation. Cell Signal. 22, 883\u2013887 (2010).","journal-title":"Cell Signal."},{"key":"2228_CR15","doi-asserted-by":"publisher","first-page":"27779","DOI":"10.1074\/jbc.M115.678789","volume":"290","author":"SG Remesh","year":"2015","unstructured":"Remesh, S. G., Santosh, V. & Escalante, C. R. Structural studies of IRF4 reveal a flexible autoinhibitory region and a compact linker domain. J. Biol. Chem. 290, 27779\u201327790 (2015).","journal-title":"J. Biol. Chem."},{"key":"2228_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1228309","volume":"338","author":"E Glasmacher","year":"2012","unstructured":"Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1\u2212IRF complexes. Science 338, 975\u2013980 (2012).","journal-title":"Science"},{"key":"2228_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1182\/bloodadvances.2017010413","volume":"2","author":"K Ochiai","year":"2018","unstructured":"Ochiai, K. et al. Zinc finger\u2212IRF composite elements bound by Ikaros\/IRF4 complexes function as gene repression in plasma cell. Blood Adv. 2, 883\u2013894 (2018).","journal-title":"Blood Adv."},{"key":"2228_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/emboj\/18.4.977","volume":"18","author":"AL Brass","year":"1999","unstructured":"Brass, A. L., Zhu, A. Q. & Singh, H. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 18, 977\u2013991 (1999).","journal-title":"EMBO J."},{"key":"2228_CR19","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1093\/nar\/gku451","volume":"42","author":"MA Care","year":"2014","unstructured":"Care, M. A. et al. SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity. Nucleic Acids Res. 42, 7591\u20137610 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2228_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.190.12.1837","volume":"190","author":"S Gupta","year":"1999","unstructured":"Gupta, S., Jiang, M., Anthony, A. & Pernis, A. B. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190, 1837\u20131848 (1999).","journal-title":"J. Exp. Med."},{"key":"2228_CR21","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.4049\/jimmunol.158.4.1848","volume":"158","author":"TA Lodie","year":"1997","unstructured":"Lodie, T. A. et al. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158, 1848\u20131856 (1997).","journal-title":"J. Immunol."},{"key":"2228_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40385-9","volume":"14","author":"S Yamanaka","year":"2023","unstructured":"Yamanaka, S. et al. Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation. Nat. Commun. 14, 4683 (2023).","journal-title":"Nat. Commun."},{"key":"2228_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2228_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1084\/jem.20011128","volume":"195","author":"J Rengarajan","year":"2002","unstructured":"Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003\u20131012 (2002).","journal-title":"J. Exp. Med."},{"key":"2228_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41589-021-00877-5","volume":"17","author":"NC Payne","year":"2021","unstructured":"Payne, N. C., Kalyakina, A. S., Singh, K., Tye, M. A. & Mazitschek, R. Bright and stable luminescent probes for target engagement profiling in live cells. Nat. Chem. Biol. 17, 1168\u20131177 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"2228_CR26","doi-asserted-by":"publisher","first-page":"67\u221273","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67\u221273 (1999).","journal-title":"J. Biomol. Screen."},{"key":"2228_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"JB Baell","year":"2018","unstructured":"Baell, J. B. & Nissink, J. W. M. Seven year itch: Pan-Assay Interference Compounds (PAINS) in 2017\u2014utility and limitations. ACS Chem. Biol. 13, 36\u201344 (2018).","journal-title":"ACS Chem. Biol."},{"key":"2228_CR28","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.dyepig.2022.110851","volume":"208","author":"L Yuan","year":"2023","unstructured":"Yuan, L., Su, Y., Cong, H., Yu, B. & Shen, Y. Application of multifunctional small molecule fluorescent probe BODIPY in life science. Dyes Pigm. 208, 110851 (2023).","journal-title":"Dyes Pigm."},{"key":"2228_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fbioe.2019.00056","volume":"7","author":"NC Dale","year":"2019","unstructured":"Dale, N. C., Johnstone, E. K. M., White, C. W. & Pfleger, K. D. G. NanoBRET: the bright future of proximity-based assays. Front. Bioeng. Biotechnol. 7, 56 (2019).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"2228_CR30","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1084\/jem.20140425","volume":"211","author":"S Carotta","year":"2014","unstructured":"Carotta, S. et al. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J. Exp. Med. 211, 2169\u20132181 (2014).","journal-title":"J. Exp. Med."},{"key":"2228_CR31","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1182\/blood.V86.7.2747.2747","volume":"86","author":"M Pettersson","year":"1995","unstructured":"Pettersson, M., Sundstr\u00f6m, C., Nilsson, K. & Larsson, L. G. The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. Blood 86, 2747\u20132753 (1995).","journal-title":"Blood"},{"key":"2228_CR32","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1172\/JCI120288","volume":"130","author":"S Song","year":"2020","unstructured":"Song, S. et al. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. J. Clin. Invest. 130, 6700\u20136717 (2020).","journal-title":"J. Clin. Invest."},{"key":"2228_CR33","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2443.2010.01427.x","volume":"15","author":"K Takahasi","year":"2010","unstructured":"Takahasi, K. et al. Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP\/p300 without overall conformational change. Genes Cells 15, 901\u2013910 (2010).","journal-title":"Genes Cells"},{"key":"2228_CR34","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1039\/D1OB01353J","volume":"19","author":"NR Burton","year":"2021","unstructured":"Burton, N. R., Kim, P. & Backus, K. M. Photoaffinity labelling strategies for mapping the small molecule\u2212protein interactome. Org. Biomol. Chem. 19, 7792\u20137809 (2021).","journal-title":"Org. Biomol. Chem."},{"key":"2228_CR35","unstructured":"Molecular Operating Environment (MOE). Chemical Computing Group ULC, 910-1010. https:\/\/www.chemcomp.com\/en\/Products.htm (2024)."},{"key":"2228_CR36","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41375-020-01078-0","volume":"35","author":"PL Fedele","year":"2021","unstructured":"Fedele, P. L. et al. The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. Leukemia 35, 2114\u20132118 (2021).","journal-title":"Leukemia"},{"key":"2228_CR37","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1021\/acsmedchemlett.1c00368","volume":"12","author":"A Bricelj","year":"2021","unstructured":"Bricelj, A. et al. Influence of linker attachment points on the stability and neosubstrate degradation of cereblon ligands. ACS Med. Chem. Lett. 12, 1733\u20131738 (2021).","journal-title":"ACS Med. Chem. Lett."},{"key":"2228_CR38","doi-asserted-by":"crossref","unstructured":"Nguyen, T. M. et al. Proteolysis-targeting chimeras with reduced off-targets. Nat. Chem. 16, 218\u2212228 (2024).","DOI":"10.1038\/s41557-023-01379-8"},{"key":"2228_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305\u2013309 (2014).","journal-title":"Science"},{"key":"2228_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0173-0","volume":"9","author":"YX Zhu","year":"2019","unstructured":"Zhu, Y. X. et al. Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood Cancer J. 9, 19 (2019).","journal-title":"Blood Cancer J."},{"key":"2228_CR41","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/cmdc.201800271","volume":"13","author":"GM Burslem","year":"2018","unstructured":"Burslem, G. M. et al. Efficient synthesis of immunomodulatory drug analogues enables exploration of structure-degradation relationships. ChemMedChem 13, 1508\u20131512 (2018).","journal-title":"ChemMedChem"},{"key":"2228_CR42","doi-asserted-by":"crossref","unstructured":"Sellar, R.S. et al. Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells. J. Clin. Invest. 132, e153514 (2022).","DOI":"10.1172\/JCI153514"},{"key":"2228_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62829-0","volume":"16","author":"M Steger","year":"2025","unstructured":"Steger, M. et al. Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. Nat. Commun 16, 7773 (2025).","journal-title":"Nat. Commun"},{"key":"2228_CR44","doi-asserted-by":"crossref","unstructured":"Wedel, J. et al. Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection. J. Clin. Invest. 135, e172218 (2025).","DOI":"10.1172\/JCI172218"},{"key":"2228_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.2019002639","volume":"135","author":"RWJ Wong","year":"2020","unstructured":"Wong, R. W. J. et al. Feed-forward regulatory loop driven by IRF4 and NF-\u03baB in adult T-cell leukemia\/lymphoma. Blood 135, 934\u2013947 (2020).","journal-title":"Blood"},{"key":"2228_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-023-00971-2","volume":"13","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma. Cell Biosci. 13, 19 (2023).","journal-title":"Cell Biosci."},{"key":"2228_CR47","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1182\/blood-2018-05-850727","volume":"132","author":"PL Fedele","year":"2018","unstructured":"Fedele, P. L. et al. IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos. Blood 132, 2166\u20132178 (2018).","journal-title":"Blood"},{"key":"2228_CR48","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acscentsci.2c01317","volume":"9","author":"ES Toriki","year":"2023","unstructured":"Toriki, E. S. et al. Rational chemical design of molecular glue degraders. ACS Cent. Sci. 9, 915\u2013926 (2023).","journal-title":"ACS Cent. Sci."},{"key":"2228_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.adk6129","volume":"385","author":"PY Ting","year":"2024","unstructured":"Ting, P. Y. et al. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction. Science 385, 91\u201399 (2024).","journal-title":"Science"},{"key":"2228_CR50","doi-asserted-by":"crossref","unstructured":"Ueno, S. et al. PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL. Oncogene 28, 4116\u22124125 (2009).","DOI":"10.1038\/onc.2009.263"},{"key":"2228_CR51","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1038\/onc.2017.79","volume":"36","author":"N Ueno","year":"2017","unstructured":"Ueno, N. et al. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Oncogene 36, 4481\u20134497 (2017).","journal-title":"Oncogene"},{"key":"2228_CR52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.autrev.2012.08.011","volume":"11","author":"WD Xu","year":"2012","unstructured":"Xu, W. D., Pan, H. F., Ye, D. Q. & Xu, Y. Targeting IRF4 in autoimmune diseases. Autoimmun. Rev. 11, 918\u2013924 (2012).","journal-title":"Autoimmun. Rev."},{"key":"2228_CR53","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi, G. et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J. Clin. Invest. 130, 3137\u20133150 (2020).","journal-title":"J. Clin. Invest."},{"key":"2228_CR54","doi-asserted-by":"publisher","first-page":"e72326","DOI":"10.1371\/journal.pone.0072326","volume":"8","author":"M Adamaki","year":"2013","unstructured":"Adamaki, M. et al. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood. PLoS ONE 8, e72326 (2013).","journal-title":"PLoS ONE"},{"key":"2228_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.stem.2020.12.017","volume":"28","author":"PK Mondala","year":"2021","unstructured":"Mondala, P. K. et al. Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption. Cell Stem Cell 28, 623\u2013636 (2021).","journal-title":"Cell Stem Cell"},{"key":"2228_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41417-024-00750-2","volume":"31","author":"M Sheykhhasan","year":"2024","unstructured":"Sheykhhasan, M. et al. CAR T therapies in multiple myeloma: unleashing the future. Cancer Gene Ther. 31, 667\u2013686 (2024).","journal-title":"Cancer Gene Ther."},{"key":"2228_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2141.2011.08689.x","volume":"154","author":"A Lopez-Girona","year":"2011","unstructured":"Lopez-Girona, A. et al. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response. Br. J. Haematol. 154, 325\u2013336 (2011).","journal-title":"Br. J. Haematol."},{"key":"2228_CR58","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1182\/bloodadvances.2022007155","volume":"7","author":"T Harada","year":"2023","unstructured":"Harada, T. et al. Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase. Blood Adv. 7, 1019\u20131032 (2023).","journal-title":"Blood Adv."},{"key":"2228_CR59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hon.3016","volume":"40","author":"A Agnarelli","year":"2022","unstructured":"Agnarelli, A. et al. Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma. Hematol. Oncol. 40, 417\u2013429 (2022).","journal-title":"Hematol. Oncol."},{"key":"2228_CR60","doi-asserted-by":"crossref","unstructured":"Harberts, A. et al. Interferon regulatory factor 4 controls effector functions of CD8+ memory T cells. Proc. Natl Acad. Sci. USA 118, e2014553118 (2021).","DOI":"10.1073\/pnas.2014553118"},{"key":"2228_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39904-5","volume":"14","author":"RP Wurz","year":"2023","unstructured":"Wurz, R. P. et al. Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation. Nat. Commun. 14, 4177 (2023).","journal-title":"Nat. Commun."},{"key":"2228_CR62","doi-asserted-by":"crossref","unstructured":"Gourisankar, S. et al. Rewiring cancer drivers to activate apoptosis. Nature 620, 417\u2212425 (2023).","DOI":"10.1038\/s41586-023-06348-2"},{"key":"2228_CR63","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.chembiol.2024.07.005","volume":"31","author":"K Raina","year":"2024","unstructured":"Raina, K. et al. Regulated induced proximity targeting chimeras\u2014RIPTACs\u2014a heterobifunctional small molecule strategy for cancer selective therapies. Cell Chem. Biol. 31, 1490\u20131502 (2024).","journal-title":"Cell Chem. Biol."},{"key":"2228_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2228_CR65","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"2228_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2228_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2228_CR68","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/ac026117i","volume":"75","author":"J Rappsilber","year":"2003","unstructured":"Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal. Chem. 75, 663\u2013670 (2003).","journal-title":"Anal. Chem."},{"key":"2228_CR69","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/jms.229","volume":"36","author":"J Peng","year":"2001","unstructured":"Peng, J. & Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom. 36, 1083\u20131091 (2001).","journal-title":"J. Mass Spectrom."},{"key":"2228_CR70","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1021\/acs.jproteome.8b00217","volume":"17","author":"J Navarrete-Perea","year":"2018","unstructured":"Navarrete-Perea, J., Yu, Q., Gygi, S. P. & Paulo, J. A. Streamlined tandem mass tag (SL-TMT) protocol: an efficient strategy for quantitative (phospho)proteome profiling using tandem mass tag-synchronous precursor selection-MS3. J. Proteome Res. 17, 2226\u20132236 (2018).","journal-title":"J. Proteome Res."},{"key":"2228_CR71","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1021\/acs.jproteome.1c00168","volume":"20","author":"J Li","year":"2021","unstructured":"Li, J. et al. TMTpro-18plex: the expanded and complete set of TMTpro reagents for sample multiplexing. J. Proteome Res. 20, 2964\u20132972 (2021).","journal-title":"J. Proteome Res."},{"key":"2228_CR72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68\u201385 (2019).","journal-title":"Nat. Protoc."},{"key":"2228_CR73","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1021\/acs.jproteome.9b00860","volume":"19","author":"DK Schweppe","year":"2020","unstructured":"Schweppe, D. K. et al. Full-featured, real-time database searching platform enables fast and accurate multiplexed quantitative proteomics. J. Proteome Res. 19, 2026\u20132034 (2020).","journal-title":"J. Proteome Res."},{"key":"2228_CR74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1021\/acs.jproteome.0c00563","volume":"20","author":"R Rad","year":"2021","unstructured":"Rad, R. et al. Improved monoisotopic mass estimation for deeper proteome coverage. J. Proteome Res. 20, 591\u2013598 (2021).","journal-title":"J. Proteome Res."},{"key":"2228_CR75","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1093\/nar\/gkp596","volume":"37","author":"D Parkhomchuk","year":"2009","unstructured":"Parkhomchuk, D. et al. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res. 37, e123 (2009).","journal-title":"Nucleic Acids Res."},{"key":"2228_CR76","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621\u2013628 (2008).","journal-title":"Nat. Methods"},{"key":"2228_CR77","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"2228_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2228_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"2228_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"2228_CR81","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02228-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:46Z","timestamp":1779958966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02228-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":81,"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1038\/s41589-026-02228-8","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.M. and N.C.P. are inventors on patent applications related to the CoraFluor TR-FRET technology used in this work (US 2022\/002254). R.S.P. is a consultant, equity holder and co-founder of Predicta Biosciences. C.S.M. has served on the Scientific Advisory Board of Adicet Bio and discloses consultant\/honoraria from Ionis, Genentech, Nerviano, Secura Bio and Oncopeptides, and research funding from EMD Serono, Karyopharm, Sanofi, Nurix, BMS, H3 Biomedicine\/Eisai, Springworks, Abcuro, Novartis and OPNA. I.M.G. has consulting or advisory roles with AbbVie, Adaptive, Amgen, Aptitude Health, Bristol Myers Squibb, GlaxoSmithKline, Huron Consulting, Janssen, Menarini Silicon Biosystems, Oncopeptides, Pfizer, Sanofi, Sognef, Takeda, The Binding Site and Window Therapeutics; has received speaker fees from Vor Biopharma and Veeva Systems; is a co-founder, equity holder and consultant for PreDICTA Biosciences; and her spouse is the CMO and an equity holder of Disc Medicine. J.Q. is a scientific co-founder and shareholder of Epiphanes, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}